ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.131,97
0,32%
S&P 500
5.480,22
0,13%
Dow Jones
38.752,91
-0,06%
Euro vs US Dollar
1,07401
0,00%
Bitcoin
64.604,59
-2,83%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV
  6. Waverley Pharma Inc (WAVE)

  7. Waverley Pharma Inc (WAVE) News

WAVE

Waverley Pharma (WAVE)

Waverley Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:WAVE
DatumZeitQuelleÜberschriftSymbolFirma
01/05/202402h08PR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
22/11/202323h00PR Newswire (Canada)Waverley Pharma Announces Changes to Board of DirectorsTSXV:WAVEWaverley Pharma Inc
02/08/202322h37PR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
20/03/202312h55PR Newswire (Canada)Waverley Pharma Provides Business UpdateTSXV:WAVEWaverley Pharma Inc
11/01/202313h55PR Newswire (Canada)Waverley Pharma Provides Update on its PARP-1 Inhibitor ProgramTSXV:WAVEWaverley Pharma Inc
05/08/202114h05PR Newswire (Canada)Waverley Pharma Announces $3,000,000 Credit FacilityTSXV:WAVEWaverley Pharma Inc
27/05/202114h05PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS EnglandTSXV:WAVEWaverley Pharma Inc
18/01/202114h40PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS ScotlandTSXV:WAVEWaverley Pharma Inc
12/11/202018h04PR Newswire (Canada)Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United StatesTSXV:WAVEWaverley Pharma Inc
23/09/202014h20PR Newswire (Canada)Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)TSXV:WAVEWaverley Pharma Inc
08/09/202016h13PR Newswire (Canada)Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the Un...TSXV:WAVEWaverley Pharma Inc
25/08/202014h15PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in ItalyTSXV:WAVEWaverley Pharma Inc
30/07/202014h25PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European CountriesTSXV:WAVEWaverley Pharma Inc
25/06/202014h15PR Newswire (Canada)Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Syn...TSXV:WAVEWaverley Pharma Inc
28/04/202022h53PR Newswire (Canada)Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial StatementsTSXV:WAVEWaverley Pharma Inc
03/02/202014h15PR Newswire (Canada)Waverley Pharma Announces Appointment of New President and CEOTSXV:WAVEWaverley Pharma Inc
08/01/202023h09PR Newswire (Canada)Waverley Pharma Announces Executive Leadership ChangesTSXV:WAVEWaverley Pharma Inc
17/12/201914h00PR Newswire (Canada)Waverley Pharma Announces Grant of Marketing Authorization in the United Kingdom for ErlotinibTSXV:WAVEWaverley Pharma Inc
11/03/201913h25PR Newswire (Canada)Waverley Pharma Provides Market Update and Fiscal 2018 Preliminary RevenueTSXV:WAVEWaverley Pharma Inc
18/12/201814h25PR Newswire (Canada)Waverley Pharma Announces Distribution Agreement and First Sale of Generic Oncology Products in the United KingdomTSXV:WAVEWaverley Pharma Inc
23/07/201814h35PR Newswire (Canada)Waverley Pharma Announces Resignation of CEO and Appointment of New CEOTSXV:WAVEWaverley Pharma Inc
27/06/201814h35PR Newswire (Canada)Waverley Pharma Announces Filing of Two Abbreviated New Drug Applications in the United StatesTSXV:WAVEWaverley Pharma Inc
25/06/201814h30PR Newswire (Canada)Waverley Pharma Announces Acquisition of two Generic Oncology Products Currently Marketed in the United KingdomTSXV:WAVEWaverley Pharma Inc
17/04/201814h30PR Newswire (Canada)Waverley Pharma Announces Filing of its Second Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
12/03/201814h00PR Newswire (Canada)Waverley Pharma Announces Filing of Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
27/10/201716h01PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - WAVE (anciennement BUFF.P)TSXV:WAVEWaverley Pharma Inc
27/10/201715h59PR Newswire (Canada)IIROC Trading Resumption - WAVE (Formerly BUFF.P)TSXV:WAVEWaverley Pharma Inc
 Showing the most relevant articles for your search:TSXV:WAVE

Kürzlich von Ihnen besucht

USOTC
ADDYY
Adidas (QX)
TG
LHA
Deutsche Lufthansa
DBI
SDXP
SDAX
TG
TUI1
Tui
TG
RHM
Rheinmetall
DBI
DAX
DAX
TG
MBG
MercedesBenz
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
TG
ALV
Allianz
TG
BAYN
Bayer
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten